MS
Michael Sardano
President and General Counsel

Michael Sardano insider trades: Sensus Healthcare (SRTS) stock buys and sales

President and General Counsel, Sensus Healthcare Last trade Nov 18, 2025 19 Form 4 filings
$0
Sold, last 12 months
0 sales
$8K
Bought, last 12 months
2 buys
8
Open-market trades
since 2022
1
Company
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Michael reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 18, 2025SRTS↑ Buy$4K
Nov 11, 2025SRTS↑ Buy$4K
Aug 13, 2025SRTS↑ Buy$3K
Feb 10, 2025SRTS↑ Buy$6K
Aug 28, 2023SRTS↑ Buy$3K
Aug 8, 2023SRTS↑ Buy$4K
May 8, 2023SRTS↑ Buy$3K
Sep 13, 2022SRTS↓ Sell$71K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other SRTS insiders

Open-market trades in the last 12 months

About Michael Sardano's insider trades

Michael Sardano is President and General Counsel at Sensus Healthcare (SRTS). Since Sep 13, 2022, Michael has reported 7 open-market purchases worth $27K and 1 sale worth $71K on SEC Form 4. In the last 12 months: 2 buys ($8K).

Their filings also include grants and awards (6 filings), shares withheld for taxes (6 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SRTS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.